IPO Aftermarket: Biotech still dominates, but tech IPOs may be coming


Wall Street Stock Market
A 'Wall St' sign is seen above two 'One Way' signs in New York. Reuters/Lucas Jackson
If it wasn’t for biotech, there would be no VC-backed IPOs through the first four months of 2016. Through the end of April, there were seven venture-backed companies that went public, including just one in April. All seven were biotech companies. ...

This content is available for Venture Capital subscribers only. Request a free trial to get access for a limited period

Venture Capital

Subscribe Now Request Trial

If you already have an active Venture Capital subscription, please sign in to view this article.